FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Enzalutamide Capsule II (Paddle) with sinker 50 Tier 1 Medium: 0.3% cetyl trimethyl ammonium bromide (CTAB) in 0.1 N HCl;Tier 2 Medium: 0.3% CTAB in 0.1 N HCl containing Pepsin 600,000 USP units/L. 900 10, 15, 20, 30 and 45 2015/05/28
Eplerenone Tablet Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Eprosartan Mesylate Tablet II (Paddle) 75 0.2 M Phosphate Buffer, pH 7.5 1000 15, 30, 45 and 60 2008/07/14
Eprosartan Mesylate/Hydrochlorothiazide Tablet II (Paddle) 75 0.2 M Phosphate Buffer, pH 7.5 1000 10, 20, 30 and 45 2008/02/19
Erdafitinib Tablet I (Basket) 75 0.01 N HCl, pH 2 500 5, 10, 15, 20, 30, 45 and 60
Ergocalciferol Capsule II (Paddle) 100 0.5 N NaOH with 10% Triton-X-100 500 15, 30, 45, 60 and 90 2010/08/05
Erlotinib HCl Tablet II (Paddle) 75 0.02% Tween 80 in 0.01 N HCl 1000 5, 10, 15, 20, 30 and 45 2018/10/18
Ertugliflozin Tablet Refer to FDA's Dissolution Guidance, 2018 2025/06/23
Erythromycin Tablet Refer to USP 2015/12/24
Erythromycin Tablet (Delayed Release) Refer to USP 2013/10/31
Erythromycin Ethylsuccinate Suspension II (Paddle) 75 Monobasic Sodium Phosphate, pH 6.8 Buffer with 1% SLS Buffer w/ 1% SLS 900 10, 20, 30, 45 and 60 2004/01/27
Erythromycin Ethylsuccinate Oral granule Develop a dissolution method 2016/06/30
Erythromycin Ethylsuccinate Tablet Refer to USP 2021/04/22
Erythromycin Ethylsuccinate/Sulfisoxazole Acetyl Granules for Oral Suspension Develop a dissolution method 2010/09/02
Escitalopram Oxalate Tablet Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Escitalopram Oxalate Capsule Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Eslicarbazepine Acetate Tablet II (Paddle) 100 Acetate Buffer, pH 4.5 1000 5, 10, 15, 20, 30 and 45 2015/08/27
Esomeprazole Magnesium Capsule (Delayed Release Pellets) Refer to USP 2015/08/27
Esomeprazole Magnesium For Oral Suspension (Delayed Release) II (Paddle 100 Acid stage: 0.1 N HCl; Buffer stage: Sodium Phosphate Buffer, pH 6.8 Acid stage: 300; Buffer stage: 1000 Acid stage: 120; Buffer stage: 10, 20, 30, 45 and 60 2010/09/02
Esomeprazole Magnesium Tablet (Orally Disintegrating, Delayed Release) II (Paddle) Acid stage: 100; Buffer stage: 75 Acid stage: 0.1 N HCl; Buffer stage: Phosphate Buffer, pH 6.8 Acid stage: 300; Buffer stage: 1000 Acid stage: 120; Buffer stage: 5, 10, 20, 30 and 45 2021/04/22

数据库说明:

当前数据更新日期:2025年12月14日。
©2006-2025 DrugFuture->FDA-Recommended Dissolution Methods Database